Home › Posts tagged Pfenex › Page 2

Tag: Pfenex

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods …

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Cyclerion Therapeutics(CYCN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.78 (USD) 04/22/2021 Weighted Valuation$2.55 (USD) Overall RatingOvervalued by 8.1% Valuation Models Adjusted Book Value: $2.68 (USD) …

Cyclerion Therapeutics (CYCN:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Cardiff Oncology(CRDF:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.80 (USD) 04/22/2021 Weighted Valuation$9.27 (USD) Overall RatingUndervalued by 5.3% Valuation Models Comparables: $10.32 (USD) Adjusted Book …

Cardiff Oncology (CRDF:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Caladrius Biosciences(CLBS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$1.56 (USD) 04/21/2021 Weighted Valuation$1.60 (USD) Overall RatingFairly valued to slightly Undervalued by 2.5% Valuation Models Comparables: $2.71 …

Caladrius Biosciences (CLBS:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Chimerix(CMRX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.25 (USD) 04/21/2021 Weighted Valuation$6.79 (USD) Overall RatingOvervalued by 17.8% Valuation Models Comparables: $6.79 (USD) Valuation Methods This …

Chimerix (CMRX:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Cidara Therapeutics(CDTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.03 (USD) 04/20/2021 Weighted Valuation$1.92 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $1.67 (USD) (in order …

Cidara Therapeutics (CDTX:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report
Finance trade manager analysing stock market indicators for best investment strategy, financial data and charts with business buildings in background

Fundamental Valuation Report Cerus(CERS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.84 (USD) 04/20/2021 Weighted Valuation$5.90 (USD) Overall RatingFairly valued to slightly Undervalued by 1.0% Valuation Models Adjusted Book …

Cerus (CERS:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Coherus BioSciences(CHRS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.27 (USD) 04/20/2021 Weighted Valuation$27.53 (USD) Overall RatingUndervalued by 93.0% Valuation Models Discounted Cash Flow: $27.53 (USD) …

Coherus BioSciences (CHRS:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Cara Therapeutics(CARA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.34 (USD) 04/19/2021 Weighted Valuation$26.30 (USD) Overall RatingFairly valued to slightly Overvalued by 3.8% Valuation Models Adjusted …

Cara Therapeutics (CARA:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report AnaptysBio(ANAB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$22.07 (USD) 04/15/2021 Weighted Valuation$29.03 (USD) Overall RatingUndervalued by 31.6% Valuation Models Comparables: $35.39 (USD) Adjusted Book Value: $35.72 …

AnaptysBio (ANAB:NAS) Fundamental Valuation Report Read more »

Read More